Universal Cells
Uguumur Erdenebayar has experience working as a Research Associate II at Universal Cells, where they conduct experiments to optimize cell differentiation protocols. Prior to this role, they worked as a Care Coordinator at THE DAWN CLINIC, a Teen Zone Volunteer at Children's Hospital Colorado, and as an Undergraduate Researcher at the University of Denver. They have also worked as an intern at COVID Saliva Testing Sites and as an IT Help Center Consultant. Uguumur is currently pursuing a Master of Science in Pharmaceutical Bioengineering at the University of Washington, having completed a Bachelor of Science in Molecular Biology at the University of Denver.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.